This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lind, R. C. Articles by Gandolfi, A. J. Search for Related Content PubMed PubMed Citation Articles by Lind, R. C. Articles by Gandolfi, A. J. Social Bookmarking                         What's this?

Hepatoprotection by Dimethyl Sulfoxide. I. Protection When Given Twenty-Four Hours After Chloroform or Bromobenzene

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721

A. Jay Gandolfi

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, gandolfi@ pharmacy.arizona.edu.

Dimethyl sulfoxide (DMSO) has previously been reported to protect against hepatotoxicity resulting from chloroform (CHCl₃) or bromobenzene (BB) when given 10 hr after the toxicant. The object of these studies was to further demonstrate the latent protective ability of DMSO by administering it at a much later time (24 hr) following toxicant exposure. In addition, a more detailed evaluation of the lesions was performed to better characterize the lesion progression and resolution. Male Sprague-Dawley rats received a hepatotoxic oral dose of either CHCl₃ (1.0 ml/kg) or BB (0.5 ml/kg) and then received 2 ml/kg DMSO intraperitoneally 24 hr later. With both toxicants, limited centrilobular lesions were already present by the time DMSO was administered. Without treatment, liver injury rapidly progressed so that by 48 hr it occupied 40-50% of the liver, with accompanying large increases in plasma alanine aminotransferase (ALT) activity. Administration of DMSO greatly attenuated lesion development for both toxicants; the area injured was reduced by more than 4-fold, accompanied by a decrease in 48 hr ALT activity of 8-16-fold. The ability of DMSO to intervene in the development of liver injury at such a late time appears to be unique and may provide insight into therapies for acute xenobioticinduced hepatitis.

Key Words: Dimethyl sulfoxide • chloroform • bromobenzene • liver injury • rat • protection • pathology

References

• Achudume AC (1991). Effects of dimethyl sulfoxide (DMSO) on carbon tetrachloride (CCl4)-induced hepatotoxicity in mice [letter]. Clin. Chim. Acta. 200: 57-58.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Antony VB, Sahn SA, and Repine JE (1983). Effect of dimethyl sulfoxide on chemotaxis of phagocytic cells. Ann. N.Y. Acad. Sci. 411: 321-323.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Beilke MA, Collins-Lech C., and Sohnle PG (1987). Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J. Lab. Clin. Med. 110: 91-96.[Web of Science][Medline] [Order article via Infotrieve]
• Brayton CF (1986). Dimethyl sulfoxide (DMSO): A review. Cornell Vet. 76: 61-90.[Web of Science][Medline] [Order article via Infotrieve]
• Brobyn RD (1975). The human toxicology of dimethyl sulfoxide. Ann. N.Y. Acad. Sci. 243: 497-506.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Casini AF, Pompella A., and Comporti M. (1985). Liver glutathione depletion induced by bromobenzene, iodobenzene, and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis. Am. J. Pathol. 118: 225-237.[Abstract]
• Chauret N., Gauthier A., and Nicoll-Griffith DA (1997). Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab. Dispos. 26: 1-4.[Web of Science]
• Corley RA, Mendrala AL, Smith FA, Staats DA, Gargas ML, Conolly RB, Andersen ME, and Reitz RH (1990). Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103: 512-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Essani NA, Fisher MA, and Jaeschke H. (1997). Inhibition of NF-KB activation by dimethyl sulfoxide correlates with suppression of TNF- formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 7: 90-96.[Web of Science][Medline] [Order article via Infotrieve]
• Fariss MW, Lippman HR, Mumaw VR, and Ray SD (1997). Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine. Toxicol. Lett. 90: 133-144.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gopinath C. and Ford JH (1975). The role of microsomal hydroxylases in the modification of chloroform hepatotoxicity in rats. Br. J. Exp. Pathol. 56: 412-422.[Web of Science][Medline] [Order article via Infotrieve]
• Hétu C., Dumont A., and Joly JG (1983). Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat. Toxicol. Appl. Pharmacol. 67: 166-177.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Isom HC, Secott T., Georgoff I., Woodworth C., and Mammaw J. (1985). Maintenance of differentiated rat hepatocytes in primary culture. Proc. Natl. Acad. Sci. USA 82: 3252-3256.[Abstract/Free Full Text]
• LaHann TR and Horita A. (1975). Effects of dimethyl sulfoxide (DMSO) on prostaglandin synthetase. Proc. West. Pharmacol. Soc. 18: 81-82.[Web of Science][Medline] [Order article via Infotrieve]
• Laskin DL, Pilaro AM, and Ji S. (1986). Potential role of activate macrophages in acetaminophen hepatotoxicity. III. Mechanism of macrophage accumulation and activation. Toxicol. Appl. Pharmacol. 86: 216-226.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lertratanangkoon K., Orkiszewski RS, and Scimeca JM (1996). Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer Res. 56: 995-1005.[Abstract/Free Full Text]
• Lim SP, Andrews FJ, and O'Brien PE (1995). Acetaminophen-induced microvascular injury in the rat liver: Protection with misoprostol. Hepatology 22: 1776-1781.[Web of Science][Medline] [Order article via Infotrieve]
• Lind RC and Gandolfi AJ (1997). Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and kidney. Toxicol. Appl. Pharmacol. 142: 201-207.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Madhu C., Gregus Z., and Klaassen CD (1989). Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: Effect of chemicals that alter acetaminophen hepatotoxicity. J. Pharmacol. Exp. Ther. 248: 1069-1077.[Abstract/Free Full Text]
• Massion PP, Linden A., Inoue, H., Mathy M., Grattan KM, and Nadel JA (1996). Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am. J. Physiol. 271: L838-L843.[Web of Science][Medline] [Order article via Infotrieve]
• Park Y., Smith RD, Combs AB, and Kehrer JP (1988). Prevention of acetaminophen-induced hepatotoxicity by dimethyl sulfoxide. Toxicology 52: 165-175.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pessayre D., Dolder A., Artigou JY, Wandscheer JC, Descatoire V., Degott C., and Benhamou JP (1979). Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 77: 264-271.[Web of Science][Medline] [Order article via Infotrieve]
• Reid WD, Krishna G., Gillette JR, and Brodie BB (1973). Biochemical mechanism of hepatic necrosis induced by aromatic hydrocarbons. Pharmacology 10: 193-214.[Web of Science][Medline] [Order article via Infotrieve]
• Rosenblum WI and El-Sabban F. (1982). Dimethyl sulfoxide (DMSO) and glycerol, hydroxyl radical scavengers, impair platelet aggregation within and eliminate the accompanying vasodilation of, injured mouse pial arterioles. Stroke 13: 35-39.[Abstract/Free Full Text]
• Russell J., Ness J., Chopra M., McMurray J., and Smith WE (1994). The assessment of the HO scavenging action of therapeutic agents. J. Pharm. Biomed. Anal. 12: 863-866.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Siegers CP (1978). Antidotal effects of dimethyl sulphoxide against paracetamol-, bromobenzene- and thioacetamide-induced hepatotoxicity. J. Pharm. Pharmacol. 30: 375-377.[Web of Science][Medline] [Order article via Infotrieve]
• Stevens JL and Anders MW (1981). Effect of cysteine, diethyl maleate, and phenobarbital treatments on the hepatotoxicity of [1H]-and [2H] chloroform. Chem.-Biol. Interact. 37: 207-217.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Torre JC de la (1983). Role of dimethyl sulfoxide in prostaglandinthromboxane and platelet systems after cerebral ischemia. Ann. N.Y. Acad. Sci. 411: 293-308.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wang PY, Kaneko H., Tsukada H., Nakano M., Nakajima T., and Sato A. (1997). Time courses of hepatic injuries induced by chloroform and by carbon tetrachloride: Comparison of biochemical and histopathological changes. Arch. Toxicol. 71: 638-645.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Winwood PJ and Arthur MJ (1993). Kupffer cells: Their activation and role in animal models of liver injury and human liver disease. Semin. Liver Dis. 13: 50-59.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 27, No. 3, 342-347 (1999)
DOI: 10.1177/019262339902700310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. H. M. Heijne, A. L. Slitt, P. J. van Bladeren, J. P. Groten, C. D. Klaassen, R. H. Stierum, and B. van Ommen Bromobenzene-Induced Hepatotoxicity at the Transcriptome Level Toxicol. Sci., June 1, 2004; 79(2): 411 - 422. [Abstract] [Full Text] [PDF]

				D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-Gossmann, A. Atfi, F. Morel, H. Ichijo, and C. Guguen-Guillouzo Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation J. Biol. Chem., December 13, 2002; 277(51): 49220 - 49229. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lind, R. C. Articles by Gandolfi, A. J. Search for Related Content PubMed PubMed Citation Articles by Lind, R. C. Articles by Gandolfi, A. J. Social Bookmarking                         What's this?